China’s microarray market

1
China Microarray Market to Be Worth 910.4
Million by 2031
2
Global China Microarray Market 2024-2031
Meticulous Researcha leading global market
research company, published a research
report titled, China Microarray Market -Global
Opportunity Analysis and Industry Forecast (2024-
2031). According to this latest publication from
Meticulous Research, the China microarray market
is expected to register a CAGR of 8.4 from 2024
to reach 910.4 million by 2031. The growth of
the China microarray market is driven by the
increasing application of microarrays for
research purposes, the growth in genomics
proteomics uses, the growing number of cancer
cases and genetic conditions, and growing RD
expenditures by the pharmaceutical
biotechnology industries. Furthermore,
advancements in microarray technology and the
increasing need for personalized medicine create
substantial growth opportunities for the China
microarray market players. However, the higher
costs of microarrays compared to other genetic
testing methods and the growing utilization of
Next-generation Sequencing (NGS) technology are
expected to hinder the growth of this market.
Microarrays' lack of sensitivity and accuracy is
a major challenge impacting market growth. Key
Players The key players operating in China
microarray market are Sino Biological, Inc.
(China), CapitalBio Technology Co., Ltd. (China),
Arrayit Corporation (U.S.), Thermo Fisher
Scientific, Inc. (U.S.), Illumina, Inc. (U.S.),
Revvity, Inc. (U.S.), Agilent Technologies, Inc.
(U.S.), Merck KGaA (Germany), and Qiagen N.V.
(Netherlands), and RayBiotech Life, Inc.
(U.S.). China Microarray Market Future
Outlook China microarray market is segmented
based on product, application, and end user. By
product, the consumables segment is predicted to
hold the largest market share of 62.6 in 2024.
This segments major market share is due to the
recurring use of assays kits in identifying the
causes of various chronic conditions, the wide
availability of consumables for disease
diagnosis, and the growing implementation of
point-of-care testing kits. In addition, key
market players are focusing on various growth
strategies, such as product launches and
strategic agreements, to strengthen their market
positions. For instance, in March 2024, QIAGEN
N.V. (Netherlands) launched QIAstat-Dx Analyzer
2.0, an upgrade of the previous analyzer that
allows users to view, comment on, and confirm
diagnostic test results from desktops or mobile
devices. By application, the drug discovery
development segment is expected to dominate in
2024, with a 51.7 share in the China microarray
market. This segment's large market share is
attributed to the rising incidence of infectious
diseases, the growing use of DNA, RNA, and
protein analysis for disease diagnosis, and the
growing RD expenditure and initiatives to
increase research capacity by introducing new
research centers due to advanced
technologies. By end user, in 2024, the
pharmaceutical and biotechnology companies
segment is projected to make up the largest share
of the China microarray market. This segment's
large market share is attributed to the growing
emphasis on drug discovery and development, the
identification of individuals with similar
genetic makeup, the in-depth understanding of
diseases and their drug responses, rising
awareness of precision medicine, and rising
pharmaceutical RD expenditure.
Meticulous Research sales_at_meticulousresearch.co
m
3
Global China Microarray Market 2024-2031

• Download Sample Report Here _at_ https//www.meticulo
  usresearch.com/download-sample- report/cp_id6004
• Key Questions Answered in the Report
• What are the high-growth market segments in terms
  of product, application, and end user?
• What was the historical market for China
  microarray across the globe?
• What are the market forecasts and estimates for
  the period 20242031?
• What are the major drivers, restraints,
  challenges, and opportunities in the China
  microarray market?
• Who are the major players in the China microarray
  market?

Contact Us Meticulous Research Email-
sales_at_meticulousresearch.com Contact Sales-
1-646-781-8004 Connect with us on LinkedIn-
https//www.linkedin.com/company/meticulous-resear
ch
Meticulous Research sales_at_meticulousresearch.co
m